250 employees
Triangle Pharmaceuticals focus on potential therapies for the human immunodeficiency virus (HIV), including AIDS, and the hepatitis B virus
1995
Triangle Pharmaceuticals Inc raised undisclosed on January 1, 1995
Investors: Venrock and SV Life Sciences